BIOENVISION TECHNOLOGY AS

3936 PORSGRUNN

Finances

Share Ownership

Return on Equity

−106,25 %

Current Ratio

0,23

Debt-to-Equity Ratio

1,25

Key figures (NOK)	2022	2021	2020	2019
Revenue	3 596 000	4 009 000	2 926 000	2 391 000
Net Income	−4 151 000	−3 852 000	−8 637 000	−955 000
Total Assets	24 637 000	21 081 000	19 538 000	18 286 000
Total Equity	3 907 000	8 058 000	11 410 000	15 747 000

Income (NOK)	2022	2021	2020	2019
Revenue	3 596 000	4 009 000	2 926 000	2 391 000
Expenditure	6 717 000	7 590 000	6 043 000	3 738 000
Operating Profit	−3 121 000	−3 582 000	−3 117 000	−1 347 000
Financial Income	7 000	2 000	18 000	6 000
Financial Costs	1 037 000	273 000	219 000	64 000
Financial Balance	−1 030 000	−271 000	−201 000	−58 000
Earnings Before Tax	−4 151 000	−3 852 000	−3 318 000	−1 405 000
Tax	0	0	5 319 000	−450 000
Net Income	−4 151 000	−3 852 000	−8 637 000	−955 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	21 063 000	16 743 000	11 896 000	15 208 000
Total Current Assets	3 574 000	4 338 000	7 642 000	3 078 000
Total Assets	24 637 000	21 081 000	19 538 000	18 286 000
Total Retained Equity	−14 901 000	−10 750 000	−6 898 000	0
Total Equity	3 907 000	8 058 000	11 410 000	15 747 000
Total Long-Term Debt	4 900 000	4 900 000	4 900 000	600 000
Total Current Debt	15 829 000	8 123 000	3 228 000	1 938 000
Total Equity and Debt	24 637 000	21 081 000	19 538 000	18 286 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	2 557 000	1 414 000	283 000	124 000
Other Income	1 040 000	2 594 000	2 643 000	2 268 000
Revenue	3 596 000	4 009 000	2 926 000	2 391 000
Cost of Goods Sold	25 000	35 000	21 000	25 000
Salary Costs	1 895 000	2 294 000	2 210 000	1 198 000
Depreciation	1 388 000	1 423 000	1 225 000	1 135 000
Impairment	0	0	0	0
Expenditure	6 717 000	7 590 000	6 043 000	3 738 000
Operating Profit	−3 121 000	−3 582 000	−3 117 000	−1 347 000
Financial Income	7 000	2 000	18 000	6 000
Financial Costs	1 037 000	273 000	219 000	64 000
Financial Balance	−1 030 000	−271 000	−201 000	−58 000
Dividends	0	0	0	0
Net Income	−4 151 000	−3 852 000	−8 637 000	−955 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	19 628 000	14 295 000	8 536 000	9 779 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	1 435 000	2 448 000	3 342 000	2 855 000
Fixtures	0	0	18 000	46 000
Total Tangible Assets	1 435 000	2 448 000	3 360 000	2 902 000
Total Fiancial Fixed Assets	0	0	0	2 528 000
Total Fixed Assets	21 063 000	16 743 000	11 896 000	15 208 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	683 000	1 230 000	4 535 000	3 078 000
Total Current Assets	3 574 000	4 338 000	7 642 000	3 078 000
Total Assets	24 637 000	21 081 000	19 538 000	18 286 000
Total Equity	3 907 000	8 058 000	11 410 000	15 747 000
Short-Term Group Debt	13 433 000	6 024 000	0	0
Total Long-Term Debt	4 900 000	4 900 000	4 900 000	600 000
Creditors	1 317 000	783 000	2 017 000	858 000
Unpaid Taxes	331 000	347 000	415 000	346 000
Dividends	0	0	0	0
Other Current Debt	748 000	969 000	796 000	735 000
Total Current Debt	15 829 000	8 123 000	3 228 000	1 938 000
Total Equity and Debt	24 637 000	21 081 000	19 538 000	18 286 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−106,25 %	−47,8 %	−75,7 %	−6,06 %
Debt-to-Equity Ratio	1,25	0,61	0,43	0,04
Operating Profit Margin	−86,79 %	−89,35 %	−106,53 %	−56,34 %
Current Ratio	0,23	0,53	2,37	1,59
Quick Ratio	0,23	0,53	2,37	1,59
Equity Ratio	0,16	0,38	0,58	0,86
Gross Profit Margin	99,3 %	99,13 %	99,28 %	98,95 %